⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KZIA News
Kazia Therapeutics Limited American Depositary Shares
Kazia Therapeutics Announces 86% Reduction in Tumor Burden in Expanded-Access Case of Metastatic TNBC Patient Treated with Paxalisib-Immunotherapy Regimen
prnewswire.com
KZIA
KZIA
Kazia Therapeutics Supports Australian MRFF-Funded Project Developing AI-Driven Sequential Therapy Strategy for DIPG/DMG
prnewswire.com
KZIA
KZIA
Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in Stage IV HER2-Positive Breast Cancer with Paxalisib Monotherapy
prnewswire.com
KZIA
KZIA